Livanova PLC Aktie News

LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova announced Vladimir Makatsaria, CEO, will present a fireside chat at the Goldman Sachs Conference in Miami, Florida at 1:20 pm ET on June 10.

LivaNova PLC (NASDAQ:LIVN ) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ET Company Participants Matthew Dodds - Senior Vice President, Corporate Development & IT Vladimir Makatsaria - Chief Executive Officer Alex Shvartsburg - Chief Financial Officer Stephanie Bolton - President, Global Epilepsy Conference Call Participants Rick Wise - Stifel Matt Taylor - Jefferies Michael Polark - Wo...

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance.

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC announced that Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer, effective May 13, 2024.

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova's wholly-owned U.S. subsidiary, LivaNova USA, Inc., is providing notice to U.S. patients regarding a cybersecurity incident in late 2023.

LONDON--(BUSINESS WIRE)-- #advancedcirculatorysupport--LivaNova will host a conference call to discuss its first-quarter 2024 results on Wed, May 1, 2024 at 1 p.m. London time (8 a.m. ET).

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova PLC announced its OSPREY clinical study has achieved a positive predictive outcome and will conclude enrollment earlier than anticipated.

LONDON--(BUSINESS WIRE)-- #cardiacsurgery--LivaNova announced the pricing of $300 million aggregate principal amount of 2.50% convertible senior notes due 2029 issued in a private offering.